The COLUMBA study supported the long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma.
Cleveland Clinic’s Asthma Center Co-Director addresses the literature examining a possible association between leukotriene-modifying agents like montelukast and suicidality.
Although asthma remains a clinical diagnosis based on episodic symptoms consistent with airflow obstruction, symptoms alone cannot reliably be used to diagnose the disease or assess its severity and control.
What does it really mean to be a leader? Sumita Khatri, MD, a physician lead for Cleveland Clinic’s Staff Experience, explores this question.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
How do you deal with stress on the job? Three of our Staff Experience physician leads offer their advice.
Adults with asthma benefit from our specialized programs and basic, translational and clinical research projects.
The development and availability of biologic agents to target specific pathophysiological elements of severe asthma has altered the landscape of care. Our asthma experts break down biologic use for patients with severe asthma.
Bronchial thermoplasty is a cost-effective treatment for asthmatics at high risk of exacerbations, but following asthmatics beyond five years will provide longer efficacy and support its cost effectiveness.
Multimodal therapy is necessary for treating severe persistent and refractory asthma. The addition of appropriately timed bronchial thermoplasty can improve asthma-related quality of life.